Form 8-K - Current report:
SEC Accession No. 0001104659-12-039873
Filing Date
2012-05-24
Accepted
2012-05-24 17:25:07
Documents
2
Period of Report
2012-05-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a12-13056_18k.htm 8-K 49650
2 EX-10.1 a12-13056_1ex10d1.htm EX-10.1 264889
  Complete submission text file 0001104659-12-039873.txt   315961
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 12868572
SIC: 2834 Pharmaceutical Preparations